NasdaqCM:MBOT

Stock Analysis Report

Executive Summary

Microbot Medical Inc., a pre-clinical medical device company, researches, designs, and develops micro-robotics assisted medical technologies targeting the minimally invasive surgery space.

Snowflake

Fundamentals

Flawless balance sheet and overvalued.

Risks

  • Microbot Medical has significant price volatility in the past 3 months.
  • Microbot Medical is covered by less than 3 analysts.

Share Price & News

How has Microbot Medical's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

-10.3%

NasdaqCM:MBOT

-1.6%

US Medical Equipment

-1.6%

US Market


1 Year Return

-45.0%

NasdaqCM:MBOT

10.2%

US Medical Equipment

-3.0%

US Market

MBOT underperformed the Medical Equipment industry which returned 10.2% over the past year.

MBOT underperformed the Market in United States of America which returned -3% over the past year.


Share holder returns

MBOTIndustryMarket
7 Day-10.3%-1.6%-1.6%
30 Day-26.1%-2.6%-5.7%
90 Day-17.1%7.4%0.2%
1 Year-45.0%-45.0%11.1%10.2%-0.8%-3.0%
3 Yearn/a65.1%60.0%38.1%29.1%
5 Yearn/a127.0%101.0%50.8%34.1%

Price Volatility Vs. Market

How volatile is Microbot Medical's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Microbot Medical undervalued based on future cash flows and its price relative to the stock market?

2.67x

Price to Book (PB) ratio


Intrinsic Value Based on Future Cash Flows

Unable to calculate intrinsic value for Microbot Medical to establish if it is available at moderate discount.

Unable to calculate intrinsic value for Microbot Medical to establish if it is available at substantial discount.


Price Based on Earnings

Microbot Medical is loss making, we can't compare its value to the US Medical Equipment industry average.

Microbot Medical is loss making, we can't compare the value of its earnings to the United States of America market.


Price Based on Expected Growth

Unable to calculate PEG ratio for Microbot Medical, we can't assess if its growth is good value.


Price Based on Value of Assets

Microbot Medical is good value based on assets compared to the US Medical Equipment industry average.


Next Steps

Future Growth

How is Microbot Medical expected to perform in the next 1 to 3 years based on estimates from 2 analysts?

22.6%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Microbot Medical has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

Past Performance

How has Microbot Medical performed over the past 5 years?

-26.9%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Microbot Medical does not make a profit and their year on year earnings growth rate was negative over the past 5 years.

Unable to compare Microbot Medical's 1-year earnings growth to the 5-year average as it is not currently profitable.

Unable to compare Microbot Medical's 1-year growth to the US Medical Equipment industry average as it is not currently profitable.


Return on Equity

It is difficult to establish if Microbot Medical has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.


Return on Assets

It is difficult to establish if Microbot Medical has efficiently used its assets last year compared to the US Medical Equipment industry average (Return on Assets) as it is loss-making.


Return on Capital Employed

It is difficult to establish if Microbot Medical improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.


Next Steps

Financial Health

How is Microbot Medical's financial position?


Financial Position Analysis

Microbot Medical is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.

Microbot Medical's cash and other short term assets cover its long term commitments.


Debt to Equity History and Analysis

Microbot Medical has no debt.

Microbot Medical currently has no debt however we can't compare to 5 years ago as we have no data for that period.


Balance Sheet

Low level of unsold assets.

Microbot Medical has no debt, it does not need to be covered by short term assets.


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Microbot Medical has sufficient cash runway for 1.2 years based on current free cash flow.

Microbot Medical has sufficient cash runway for 1.2 years if free cash flow continues to grow at historical rates of 57.2% each year.


Next Steps

Dividend

What is Microbot Medical's current dividend yield, its reliability and sustainability?


Dividend Yield and Payments Analysis

Unable to evaluate Microbot Medical's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.

Unable to evaluate Microbot Medical's dividend against the top 25% market benchmark as the company has not reported any payouts.

Unable to perform a dividend volatility check as Microbot Medical has not reported any payouts.

Unable to verify if Microbot Medical's dividend has been increasing as the company has not reported any payouts.


Current Payout to Shareholders

Unable to calculate sustainability of dividends as Microbot Medical has not reported any payouts.


Future Payout to Shareholders

Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.


Next Steps

Management

What is the CEO of Microbot Medical's salary, the management and board of directors tenure and is there insider trading?

2.8yrs

Average management tenure


CEO

Harel Gadot (46yo)

2.8yrs

Tenure

US$1,009,467

Compensation

Mr. Harel Gadot is the Founder of MEDX Ventures Group LLC and serves as its Chairman. Mr. Gadot has been the Chief Executive Officer and President of Microbot Medical Inc. since November 28, 2016 and its C ...


CEO Compensation Analysis

Harel's remuneration is higher than average for companies of similar size in United States of America.

Harel's compensation has increased whilst company is loss making.


Management Age and Tenure

2.8yrs

Average Tenure

50yo

Average Age

The tenure for the Microbot Medical management team is about average.


Board Age and Tenure

2.8yrs

Average Tenure

58yo

Average Age

The average tenure for the Microbot Medical board of directors is less than 3 years, this suggests a new board.


Insider Trading

No 3 month open market individual insider trading information.


Recent Insider Transactions

SellUS$3,623,17017 Jan 19
Alliance Investment Management Ltd
EntityCompany
Shares402,628
Max PriceUS$11.78
BuyUS$378,64917 Jan 19
Alliance Investment Management Ltd
EntityCompany
Shares102,309
Max PriceUS$10.99

Ownership Breakdown


Management Team

  • Moshe Shoham (67yo)

    Co-Founder

    • Tenure: 0.0yrs
    • Compensation: US$33.65k
  • Simon Sharon

    CTO & Chairman of Scientific Advisory Board

    • Tenure: 0.0yrs
  • David Naim (50yo)

    Chief Financial Officer

    • Tenure: 2.8yrs
    • Compensation: US$96.92k
  • Eric Leuthardt

    Scientific Director & Member of Scientific Advisory Board

    • Tenure: 0.0yrs
  • Harel Gadot (46yo)

    Co-Founder

    • Tenure: 2.8yrs
    • Compensation: US$1.01m

Board Members

  • Yoav Waizer (53yo)

    Director

    • Tenure: 2.8yrs
    • Compensation: US$45.98k
  • Scott Burell (54yo)

    Director

    • Tenure: 2.8yrs
    • Compensation: US$54.73k
  • Moshe Shoham (67yo)

    Co-Founder

    • Tenure: 0.0yrs
    • Compensation: US$33.65k
  • Simon Sharon

    CTO & Chairman of Scientific Advisory Board

    • Tenure: 0.0yrs
  • Yossi Bornstein (60yo)

    Co-Founder & Director

    • Tenure: 2.8yrs
    • Compensation: US$54.73k
  • Eric Leuthardt

    Scientific Director & Member of Scientific Advisory Board

    • Tenure: 0.0yrs
  • Harel Gadot (46yo)

    Co-Founder

    • Tenure: 2.8yrs
    • Compensation: US$1.01m
  • Martin Madden (58yo)

    Director

    • Tenure: 2.5yrs
    • Compensation: US$54.73k
  • Laxmin Laxminarain (61yo)

    Director

    • Tenure: 1.7yrs
    • Compensation: US$40.98k
  • Eyal Morag

    Scientific Advisor

    • Tenure: 0.7yrs

Company Information

Microbot Medical Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Microbot Medical Inc.
  • Ticker: MBOT
  • Exchange: NasdaqCM
  • Founded: 2010
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: US$21.323m
  • Shares outstanding: 4.31m
  • Website: https://www.microbotmedical.com

Number of Employees


Location

  • Microbot Medical Inc.
  • 25 Recreation Park Drive
  • Unit 108
  • Hingham
  • Massachusetts
  • 2043
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
CY9DDB (Deutsche Boerse AG)YesNew Common StockDEEURNov 2016
MBOTNasdaqCM (Nasdaq Capital Market)YesNew Common StockUSUSDNov 2016
CY9CDUSE (Dusseldorf Stock Exchange)YesNew Common StockDEEURNov 2016

Biography

Microbot Medical Inc., a pre-clinical medical device company, researches, designs, and develops micro-robotics assisted medical technologies targeting the minimally invasive surgery space. The company, thr ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/08/25 00:49
End of Day Share Price2019/08/23 00:00
Earnings2019/06/30
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.